Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.30
-0.30 (-1.46%)
At close: Jul 15, 2026
Vistin Pharma ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 449.47 | 452.29 | 429.5 | 438.33 | 304.85 | 278.62 | |
Revenue Growth (YoY) | 2.00% | 5.31% | -2.01% | 43.78% | 9.41% | 9.74% |
Cost of Revenue | 150.18 | - | 149.97 | 176.64 | 138.06 | 96.1 |
Gross Profit | 299.29 | 452.29 | 279.53 | 261.69 | 166.79 | 182.53 |
Selling, General & Admin | 98.79 | - | 94.22 | 93.14 | 78.97 | 73.43 |
Depreciation & Amortization Expenses | 23.46 | - | 19.03 | 17.35 | 12.28 | 10.61 |
Other Operating Expenses | 88.51 | - | 80.99 | 82.61 | 81.63 | 65.24 |
Total Operating Expenses | 210.76 | 0 | 194.24 | 193.09 | 172.88 | 149.28 |
Operating Income | 88.54 | 452.29 | 85.3 | 68.6 | -6.1 | 33.25 |
Interest Income | 18.96 | - | 9.72 | 20.84 | 9.55 | 6.07 |
Interest Expense | -11.92 | - | -14.56 | -30.92 | -9.47 | -7.32 |
Other Non-Operating Income (Expense) | 7.04 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 14.08 | - | -4.84 | -10.08 | 0.09 | -1.26 |
Pretax Income | 95.58 | 452.29 | 80.45 | 58.52 | -6.01 | 32 |
Provision for Income Taxes | 21.03 | - | 17.7 | 12.92 | 1.29 | -7.13 |
Net Income | 74.55 | 452.29 | 62.75 | 45.6 | -7.3 | 39.12 |
Net Income to Common | 74.55 | 452.29 | 62.75 | 45.6 | -4.72 | 24.87 |
Net Income Growth | -2.92% | 620.79% | 37.62% | - | - | - |
Shares Outstanding (Basic) | 44 | 44 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 44 | 44 | 44 | 44 | 44 | 44 |
Shares Change (YoY) | 0.05% | - | - | - | - | - |
EPS (Basic) | 1.68 | 1.69 | 1.42 | 1.03 | -0.11 | 0.56 |
EPS (Diluted) | 1.68 | 1.69 | 1.42 | 1.03 | -0.11 | 0.56 |
EPS Growth | 1.21% | 19.01% | 37.86% | - | - | - |
Free Cash Flow | - | 55.5 | 0 | 72.69 | -74.8 | -18.26 |
Free Cash Flow Per Share | - | 1.25 | - | 1.64 | -1.69 | -0.41 |
Dividends Per Share | 1.500 | 1.500 | 1.250 | 1.000 | 0.750 | 0.750 |
Dividend Growth | - | 20.00% | 25.00% | 33.33% | - | 50.00% |
Gross Margin | 66.59% | 100.00% | 65.08% | 59.70% | 54.71% | 65.51% |
Operating Margin | 19.70% | 100.00% | 19.86% | 15.65% | -2.00% | 11.93% |
Profit Margin | 16.59% | 100.00% | 14.61% | 10.40% | -2.39% | 14.04% |
FCF Margin | - | 12.27% | 0.00% | 16.58% | -24.54% | -6.55% |
EBITDA | 88.54 | 452.29 | 85.3 | 85.95 | 6.19 | 43.86 |
EBITDA Margin | 19.70% | 100.00% | 19.86% | 19.61% | 2.03% | 15.74% |
EBIT | 88.54 | 452.29 | 85.3 | 68.6 | -6.1 | 33.25 |
EBIT Margin | 19.70% | 100.00% | 19.86% | 15.65% | -2.00% | 11.93% |
Effective Tax Rate | 22.00% | 0.00% | 22.01% | 22.08% | -21.52% | -22.28% |